KLF1 E325K-associated Congenital Dyserythropoietic Anemia Type IV: Insights Into the Variable Clinical Severity

Area of Science:

• Genetics
• Hematology
• Molecular Biology

Background:

• Congenital dyserythropoietic anemia type IV (CDA IV) is a rare inherited blood disorder.
• The KLF1-E325K mutation is a known cause of CDA IV, but severe phenotypes require further investigation.

Observation:

• A patient with KLF1-E325K CDA IV presented with severe fetal anemia, hydrops fetalis, and transfusion dependence.
• The patient also exhibited complete sex reversal, with the cause remaining undetermined.
• Erythrocyte membrane abnormalities were identified in the patient and parents, linked to alpha-spectrin gene variants.

Findings:

• Hypomorphic alleles in SEC23B and YARS2 were detected in the patient.
• Functional erythrocyte membrane abnormalities were attributed to alpha-spectrin gene variants.
• The severe phenotype suggests a complex genetic contribution beyond the primary KLF1-E325K mutation.

Implications:

• Coinheritance of variants in erythrocyte-related genes may significantly influence the clinical severity of KLF1-E325K CDA IV.
• Understanding these genetic interactions is crucial for diagnosing and managing severe cases of CDA IV.
• Further research into the interplay of these genes could reveal novel therapeutic targets for dyserythropoietic anemias.